Skip to main content
Clinical Trials/ISRCTN85205641
ISRCTN85205641
Completed
Not Applicable

Efficacy of fibrin sealant in reducing resection surface crelated complications after partial liver resections (FRESCO trial): A Dutch, multicentre, prospective, randomised, controlled trial

Johnson and Johnson Medical Limited (UK)0 sites600 target enrollmentMay 28, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Johnson and Johnson Medical Limited (UK)
Enrollment
600
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 28, 2010
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Johnson and Johnson Medical Limited (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients aged greater than or equal to 18 years, either sex
  • 2\. Undergo liver resections (at least one segment) for benign or malignant tumours or metastatic tumours, or
  • 3\. Undergo liver resection in combination with radiofrequency ablation (RFA)

Exclusion Criteria

  • 1\. Aged less than 18 years
  • 2\. Undergo liver resections with extrahepatic biliary resection and reconstruction (Klatskin tumours)
  • 3\. Cirrhosis
  • 4\. Other disorders of haemostasis
  • 5\. Polycystic liver disease
  • 6\. Any associated operative gastrointestinal procedures (a needle catheter jejunostomy is not excluded)
  • 7\. Wedge resections
  • 8\. Pregnancy
  • 9\. History of hypersensitivity, allergy or anaphylactic reaction to any plasma derived product, including fibrin sealant

Outcomes

Primary Outcomes

Not specified

Similar Trials